TCBP: TC Biopharm O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Joriy PEG koeffitsiyenti TC Biopharm (TCBP) kompaniyasining bozor qiymati dinamikasini namoyish etadi, bunda 0.00 qiymati ushbu holatni aks ettiradi. Emitent immunoterapiya rivojlantirish jarayoniga ESG tamoyillarini integratsiya qilib, o'z laboratoriyalarining ekologik barqarorligini ta'minlamoqda. Onkologik dori vositalariga bo'lgan talab barqaror qolmoqda, iqtisodiy bog'liqlik esa faqat ventura kapital investitsiyalarining mavjudligi bilan cheklangan. Strategiya xalqaro sinovlar va global hamkorlarni jalb qilish orqali gamma-delta T-hujayralar platformasini kengaytirishga asoslangan.
TC Biopharm (TCBP) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati TC Biopharm|TCBP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi tcbiopharm.com|TCBP - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar TC BioPharm Ltd|TCBP - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori TC BioPharm|Tezkor likvidlik ko‘rsatkichi tcbiopharm.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
TCBP - Sof daromad|Kutilayotgan sof daromad TC Biopharm|TCBP - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati TC BioPharm Ltd|TCBP - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati TC BioPharm Ltd|TCBP - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda TC BioPharm|TCBP - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi tcbiopharm.com|TCBP - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi TC Biopharm
Kompaniyaning umumiy tahlili:TCBP - TC BioPharm (Holdings) Plc
Faoliyati qat'iy ravishda FDA standartlari bilan tartibga solinadigan TC Biopharm (TCBP) biofarmatsevtika biznesi uchun PEG koeffitsiyenti tarixi qat'iy tibbiy protokollar ostidagi kapitalizatsiya samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika joriy foyda koeffitsiyentini o'sish sur'ati bilan bog'laydi, bunda birdan past qiymat kompaniyaning kengayishiga nisbatan fundamental past baholanganligidan dalolat beradi.
TC Biopharm kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|Pharvaris Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ABCL: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori tourmalinebio.com|Narx-foyda va o‘sish multiplikatori PGEN|PHAR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NKTR|Narxning foydaga va o‘sish sur’atiga nisbati UPB (Upstream Pharma)|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunome.com (IMNM)|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PVLA (Pieris Corp)|SVRA (Savara Inc.) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|PEG multiplikatori Astria Therapeutics Inc (ATXS)|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RAPT|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|aclaristx.com (ACRS) - Narx-foyda va o‘sish multiplikatori|KYTX (Kyverna Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|TLSA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Ventyx Biosciences, Inc (VTYX)|PEG multiplikatori THTX|Narxning foydaga va o‘sish sur’atiga nisbati AVTX (avalotx.com)|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ZURA|ATYR: PEG multiplikatori|Adagene Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|IMA (ImageneBio) - PEG multiplikatori|PEG multiplikatori Shattuck Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunic IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|InflaRx GmbH - PEG multiplikatori|XFOR - PEG multiplikatori|ACET (adicetbio.com) - Narx-foyda va o‘sish multiplikatori|Celularity - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INMB (INmune Bio, Inc.) - PEG multiplikatori|barinthusbio.com (BRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|Narx-foyda va o‘sish multiplikatori SAB Biotherapeutics Inc. SABS|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|ENLV - Narx-foyda va o‘sish multiplikatori|QTTB: Narx-foyda va o‘sish multiplikatori|GOVX - PEG multiplikatori|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti IBIO|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda XTL Bio XTLB|Narx-foyda va o‘sish multiplikatori BOLT (Bolt Biotherapeutics)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HCWB|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM - Narx-foyda va o‘sish multiplikatori|ADTX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GRI (GRI Bio Corporation)|XRTX: PEG multiplikatori|HIND (reshapelifesciences.com) - Narxning foydaga va o‘sish sur’atiga nisbati|REVB (Revelation Biosciences, Inc.) - PEG multiplikatori|Indaptus Therapeutics Inc (INDP) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|CALI - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Affimed N.V. AFMD|ALLK (Allakos Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|HOOKIPA - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IGMS (IGM Biosciences, Inc.)|ITOS: PEG multiplikatori|Ocean Biomedical Corp (OCEA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
